Amyloidosis: open trials in Mexico

• NCT06128629

  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  Trial Treatment · Phase 3 · Intellia Therapeutics

  Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City

  Registry updated 2026-11-04

• NCT07052903

  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  Trial Treatment · Phase 3 · Alnylam Pharmaceuticals

  Tlalpan

  Registry updated 2026-10-20

• NCT07223203

  TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  Trial Treatment · Phase 3 · Alnylam Pharmaceuticals

  Guadalajara · Tlalpan

  Registry updated 2026-10-08

• NCT06563895

  Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company

  National Institute of Medical Sciences and Nutrition - Salvador Zubiran(INCMNSZ), Tlalpan

  Registry updated 2026-08-04

All Amyloidosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error